SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer

被引：28

作者：

Khademi, Bijan ^{[1
]}

Razmkhah, Mahboobeh ^{[1
]}

Erfani, Nasrollah ^{[1
]}

Gharagozloo, Marjan ^{[2
]}

Ghaderi, Abbas ^{[1
]}

机构：

[1] Shiraz Univ Med Sci, Shiraz Inst Canc Res, Dept ENT, Shiraz, Iran

[2] Shiraz Univ Med Sci, Dept Immunol, Shiraz, Iran

来源：

PATHOLOGY & ONCOLOGY RESEARCH | 2008年 / 14卷 / 01期

关键词：

head and neck cancer; SDF-1; CCR5; polymorphism; metastasis;

D O I：

10.1007/s12253-008-9007-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The frequency of SDF1-3'A and CCR5 Delta 32 in patients with head and neck cancer were determined in this study. The frequencies of alleles and genotypes of SDF-1 and CCR5 were assessed by PCR method in 156 patients with malignant head and neck cancer, 125 (80.1%) cases with squamous cell carcinoma and 31 (19.9%) cases with salivary gland tumors and compared with 262 age-sex matched healthy control individuals. SDF-1 genotypes in patients with SCC of head and neck, but not with salivary gland tumors, showed a statistically significant difference compared to the normal group (P < 0.005 for SCC and P = 0.3 for salivary gland tumors). There were no significant differences in the frequencies of SDF1-3'A allele, CCR5 genotypes and alleles between patients and controls. Based on the present study SDF1-3A may be associated with the susceptibility of patients to SCC of head and neck cancer.

引用

页码：45 / 50

页数：6

共 49 条

[1] The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood [J].

Aiuti, A ;

Webb, IJ ;

Bleul, C ;

Springer, T ;

GutierrezRamos, JC .

JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :111-120

[2]

Almofti A, 2004, INT J ONCOL, V25, P65

[3] Characterization of chemokines and their receptors in the central nervous system: physiopathological implications [J].

Bajetto, A ;

Bonavia, R ;

Barbero, S ;

Schettini, G .

JOURNAL OF NEUROCHEMISTRY, 2002, 82 (06) :1311-1329

[4] Chemokine biology in cancer [J].

Balkwill, F .

SEMINARS IN IMMUNOLOGY, 2003, 15 (01) :49-55

[5] A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) [J].

Bleul, CC ;

Fuhlbrigge, RC ;

Casasnovas, JM ;

Aiuti, A ;

Springer, TA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1101-1109

[6] Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation [J].

Bonavia, R ;

Bajetto, A ;

Barbero, S ;

Pirani, P ;

Florio, T ;

Schettini, G .

TOXICOLOGY LETTERS, 2003, 139 (2-3) :181-189

[7] Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil [J].

Cavassin, GGD ;

De Lucca, FL ;

André, ND ;

Covas, DT ;

Fungaro, MHP ;

Voltarelli, JC ;

Watanabe, MAE .

BLOOD CELLS MOLECULES AND DISEASES, 2004, 33 (01) :90-93

[8] Balanced polymorphism selected by genetic versus infectious human disease [J].

Dean, M ;

Carrington, M ;

O'Brien, SJ .

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2002, 3 :263-292

[9] The Δ32 allele distribution of the CCR5 gene and its relationship with certain cancers in a Turkish population [J].

Degerli, N ;

Yilmaz, E ;

Bardakci, F .

CLINICAL BIOCHEMISTRY, 2005, 38 (03) :248-252

[10]

Delgado MB, 2001, EUR J IMMUNOL, V31, P699, DOI 10.1002/1521-4141(200103)31:3<699::AID-IMMU699>3.0.CO

← 1 2 3 4 5 →